Small-molecule therapy developer Xgene Pharma has received $20m in a Ping An Ventures-led round that also featured a subsidiary of Sinar Mas.

Intel, Axa and Reinsurance Group of America all invested in K4Connect, the developer of an operating system for connected household devices catered to older and disabled users.

Alexandria Real Estate Equities-backed genome engineering platform developer Synthego took its overall funding to $160m in a round led by Founders Fund.

The drug injection device developer has reached the first close of a $50m round, with Sanofi leading the tranche and Cincinnati Children’s Hospital and Cleveland Clinic also investing.

Alexandria Venture Investments invested in the genetic drug developer, which completed a series B round that followed a $40m series A in January.

Kyoto University Innovation Capital is partnering Infinite Capital Holding as part of efforts to let spinouts conduct clinical trials in China.

Ohio Innovation Fund has returned to support a first series B tranche for Enable Injections, which is targeting a $50m final close.

Scythian Biosciences is investing $88m directly in Verano and will sell its subsidiary 3 Boys Farm to the cannabis producer in return for another $100m worth of shares.

Gauss Surgical has received series C funding from SoftBank and eight healthcare providers including Northwell Health, OSF Healthcare and Providence Healthcare.

Stanford-StartX Fund's portfolio company Gauss Surgical has received series C funding from SoftBank and eight healthcare providers.